Trial intelligence / Profile preview

CARDS: Atorvastatin for Cardiovascular Prevention in Type 2 Diabetes

NCT00327418Phase 4Completed

Sponsor
Pfizer
Start
Jan 1997
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in cardiovascular disease (CVD), sponsored by Pfizer. Started Jan 1997; status: completed.

02

Drugs

atorvastatin
03

Conditions

cardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT00327418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00327418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call